The following table shows the list of Horizon 2020 projects developed by "DE DUVE INSTITUTE". Projects are ordered by starting date.
Click on table headers to rearrange data.
# | acronym | programme | role | EC contrib. | start | views |
---|---|---|---|---|---|---|
1 | MESI-STRAT | H2020-EU.3.1.1. | participant | 289˙000.00 | 2018-01-01 | 714 |
2 | Pan3DP | H2020-EU.1.2.1. | participant | 421˙250.00 | 2018-10-01 | 403 |
3 | V.A. Cure | H2020-EU.1.3.1. | coordinator | 512˙640.00 | 2019-03-01 | 402 |
4 | IMMUcan | H2020-EU.3.1.7. | participant | 0.00 | 2019-03-01 | 353 |
5 | TheraLymph | H2020-EU.3.1.3. | participant | 608˙335.00 | 2020-01-01 | 462 |
totale | 1˙831˙225.00 |
This organization collaborated with partners in 15 countries.
Within the project MESI-STRAT this organization got in touch with:
role | cy | shortname | name |
---|---|---|---|
participant | NL | SysBioSim B.V. | SYSBIOSIM BV (PRC) |
participant | DE | PATH Biobank | STIFTUNG PATIENTS TUMORBANK OF HOPE- DIE PATIENTENEIGENE TUMORGEWEBEBANK DER HOFFNUNG (PATH) (REC) |
participant | DE | Neuroimmun GmbH | NEUROIMMUN GMBH (PRC) |
participant | ES | VHIO | FUNDACIO PRIVADA INSTITUT D'INVESTIGACIO ONCOLOGICA DE VALL-HEBRON (REC) |
participant | DE | HITS | HITS GGMBH (REC) |
participant | DE | UKL-HD | UNIVERSITATSKLINIKUM HEIDELBERG (HES) |
participant | UK | UDUR | UNIVERSITY OF DURHAM (HES) |
coordinator | AT | LFU | UNIVERSITAET INNSBRUCK (HES) |
participant | NO | UiT | UNIVERSITETET I TROMSOE - NORGES ARKTISKE UNIVERSITET (HES) |
participant | NL | UMCG | ACADEMISCH ZIEKENHUIS GRONINGEN (HES) |
participant | NO | UiB | UNIVERSITETET I BERGEN (HES) |
participant | UK | UNEW | UNIVERSITY OF NEWCASTLE UPON TYNE (HES) |
participant | DE | DKFZ | DEUTSCHES KREBSFORSCHUNGSZENTRUM HEIDELBERG (REC) |
participant | DE | Charite | CHARITE - UNIVERSITAETSMEDIZIN BERLIN (HES) |
Within the project Pan3DP this organization got in touch with:
role | cy | shortname | name |
---|---|---|---|
participant | FR | POIETIS | POIETIS (PRC) |
participant | IL | TAU | TEL AVIV UNIVERSITY (HES) |
participant | IL | TECHNION | TECHNION - ISRAEL INSTITUTE OF TECHNOLOGY (HES) |
participant | CH | ETH Zürich | EIDGENOESSISCHE TECHNISCHE HOCHSCHULE ZUERICH (HES) |
coordinator | UK | KCL | KING'S COLLEGE LONDON (HES) |
Within the project V.A. Cure this organization got in touch with:
role | cy | shortname | name |
---|---|---|---|
partner | FI | TAU | TAMPEREEN KORKEAKOULUSAATIO SR (HES) |
participant | FI | FA | SINGH PRATEEK (PRC) |
partner | BE | VASCAPA | BELGIAN VASCULAR ANOMALY PATIENT ASSOCIATION (OTH) |
partner | DE | Bayer AG | BAYER AKTIENGESELLSCHAFT (PRC) |
partner | DE | LLS Rowiak | LLS ROWIAK LASERLABSOLUTIONS GMBH (PRC) |
partner | DE | Sysmex Inostics GmbH | Sysmex Inostics GmbH (PRC) |
partner | SE | Perimed AB | Perimed AB (PRC) |
partner | BE | CUSL | CLINIQUES UNIVERSITAIRES SAINT-LUC (REC) |
partner | SE | OLINK BIOSCIENCE AB | MOLECULINK AB (PRC) |
participant | FI | UOULU | OULUN YLIOPISTO (HES) |
participant | DE | UP | UNIVERSITAET POTSDAM (HES) |
participant | FI | UTA | TAMPEREEN YLIOPISTO (HES) |
participant | SE | MEDIMMUNE | ASTRAZENECA AB (PRC) |
participant | SE | KI | KAROLINSKA INSTITUTET (HES) |
participant | SE | UU | UPPSALA UNIVERSITET (HES) |
participant | DE | MPG | MAX-PLANCK-GESELLSCHAFT ZUR FORDERUNG DER WISSENSCHAFTEN EV (REC) |
participant | FR | INSERM | INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (REC) |
Within the project IMMUcan this organization got in touch with:
role | cy | shortname | name |
---|---|---|---|
participant | FR | LCC | LIGUE NATIONALE CONTRE LE CANCER (REC) |
participant | FR | OWKIN | OWKIN FRANCE (PRC) |
participant | DE | Bayer AG | BAYER AKTIENGESELLSCHAFT (PRC) |
participant | US | AbbVie | ABBVIE INC (PRC) |
participant | BE | IJB | INSTITUT JULES BORDET (HES) |
participant | UK | Eli Lilly | Eli Lilly and Company Limited (PRC) |
participant | FR | IRIS | INSTITUT DE RECHERCHES INTERNATIONALES SERVIER (PRC) |
participant | FR | PIERRE FABRE | INSTITUT DE RECHERCHE PIERRE FABRESAS (PRC) |
participant | FR | CLB | CENTRE DE LUTTE CONTRE LE CANCER LEON BERARD (REC) |
participant | FR | SARD | SANOFI-AVENTIS RECHERCHE & DEVELOPPEMENT (PRC) |
participant | LU | LIH | LUXEMBOURG INSTITUTE OF HEALTH (REC) |
participant | BE | JANSSEN | JANSSEN PHARMACEUTICA NV (PRC) |
participant | LU | EPF | FORUM EUROPEEN DES PATIENTS (FPE) (OTH) |
coordinator | BE | EORTC | EUROPEAN ORGANISATION FOR RESEARCH AND TREATMENT OF CANCER AISBL (REC) |
participant | ES | CRG | FUNDACIO CENTRE DE REGULACIO GENOMICA (REC) |
participant | CH | CHUV | CENTRE HOSPITALIER UNIVERSITAIRE VAUDOIS (PUB) |
participant | CH | SIB | SIB INSTITUT SUISSE DE BIOINFORMATIQUE (REC) |
participant | FR | IC | INSTITUT CURIE (REC) |
participant | UK | UoB | THE UNIVERSITY OF BIRMINGHAM (HES) |
participant | UK | GSK | GLAXOSMITHKLINE RESEARCH AND DEVELOPMENT LTD. (PRC) |
participant | DE | Merck | MERCK KOMMANDITGESELLSCHAFT AUF AKTIEN (PRC) |
participant | CH | UZH | UNIVERSITAT ZURICH (HES) |
participant | IL | WEIZMANN | WEIZMANN INSTITUTE OF SCIENCE (HES) |
participant | UK | KCL | KING'S COLLEGE LONDON (HES) |
participant | BE | KUL | KATHOLIEKE UNIVERSITEIT LEUVEN (HES) |
participant | DE | CHA | CHARITE - UNIVERSITAETSMEDIZIN BERLIN (HES) |
participant | FR | INSERM | INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (REC) |
Within the project TheraLymph this organization got in touch with:
role | cy | shortname | name |
---|---|---|---|
participant | FR | FTX | FLASH THERAPEUTICS (PRC) |
participant | CH | UNIL | UNIVERSITE DE LAUSANNE (HES) |
participant | FR | CHUT | CENTRE HOSPITALIER UNIVERSITAIRE DE TOULOUSE (HES) |
participant | CZ | CUNI | UNIVERZITA KARLOVA (HES) |
participant | FR | IT | INSERM - TRANSFERT SA (PRC) |
participant | BE | ULG | UNIVERSITE DE LIEGE (HES) |
participant | SE | UU | UPPSALA UNIVERSITET (HES) |
participant | FI | UH | HELSINGIN YLIOPISTO (HES) |
coordinator | FR | INSERM | INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (REC) |
participant | FR | CNRS | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE CNRS (REC) |